Senate health committee Chair Bernie Sanders (I-VT) calls on Novo Nordisk to dramatically lower the prices of its semaglutide medications Ozempic and Wegovy, claiming it costs the company only $5 a month to make Ozempic and the high price tags of these medications could bankrupt Medicare. But industry experts say the $5 cost analysis doesn’t take into account the cost of transportation, storage, advertising and promotion. “Ozempic has the potential to be a game changer in the diabetes and obesity...